Mosaic ImmunoEngineering (CPMV) Treasury Shares (2011 - 2026)
Mosaic ImmunoEngineering (CPMV) posted quarterly Treasury Shares of $14.6 million for Q2 2020, little changed year-over-year from $14.6 million in Q2 2019, and little changed quarter-over-quarter from $14.6 million in Q1 2020.
Mosaic ImmunoEngineering (CPMV) Treasury Shares (2011 - 2026) Analysis & Trends
Mosaic ImmunoEngineering's Treasury Shares history runs 10 years deep, the most recent figure standing at $14.6 million for Q2 2020.
- In Q2 2020, Treasury Shares changed 0.0% year-over-year to $14.6 million; the TTM figure through May 2020 stood at $14.6 million (changed 0.0% YoY), while the FY2020 annual figure was $14.6 million, changed 0.0% from the prior year.
- Treasury Shares for Q2 2020 stood at $14.6 million, roughly flat from $14.6 million in the prior quarter.
- The five-year high for Treasury Shares was $1.7 million in Q1 2022, with the low at $326678.0 in Q4 2025.
- The 5-year median for Treasury Shares is $541957.0 (2022), against an average of $863814.6.
- Peak annual rise in Treasury Shares reached 0.0% in 2016, while the deepest fall reached 0.0% in 2016.
- Mosaic ImmunoEngineering's Treasury Shares stood at $14.6 million in 2016, then changed by 0.0% to $14.6 million in 2017, then changed by 0.0% to $14.6 million in 2018, then changed by 0.0% to $14.6 million in 2019, then changed by 0.0% to $14.6 million in 2020.
- Business Quant data shows CPMV's Treasury Shares at $14.6 million in Q2 2020, $14.6 million in Q1 2020, and $14.6 million in Q4 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.83 Bn | 130.98 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.79 Bn | 77.79 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 64.95 Bn | 59.77 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.59 Bn | 53.46 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.93 Bn | 36.83 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.52 Bn | 28.21 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 27.98 Bn | 9.58 Bn | 668.28 Mn | 8.96 Mn |
| 8 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - | 2.72 Mn |
| 10 | Mosaic ImmunoEngineering | 3.68 Mn | 3.68 Mn | - | 1.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.34 Mn |
| Mar 31, 2026 | 1.34 Mn |
| Dec 31, 2025 | 326,678.00 |
| Dec 31, 2025 | 326,678.00 |
| Sep 30, 2025 | 395,157.00 |
| Sep 30, 2025 | 395,157.00 |
| Jun 30, 2025 | 510,513.00 |
| Jun 30, 2025 | 510,513.00 |
| Mar 31, 2025 | 1.14 Mn |
| Mar 31, 2025 | 1.14 Mn |
| Dec 31, 2024 | 510,513.00 |
| Dec 31, 2024 | 510,513.00 |
| Sep 30, 2024 | 1.11 Mn |
| Sep 30, 2024 | 1.11 Mn |
| Jun 30, 2024 | 1.11 Mn |
| Jun 30, 2024 | 1.11 Mn |
| Mar 31, 2024 | 541,957.00 |
| Mar 31, 2024 | 541,957.00 |
| Dec 31, 2023 | 541,957.00 |
| Dec 31, 2023 | 541,957.00 |